Fosun International LTD Clearside Biomedical, Inc. Transaction History
Fosun International LTD
- $91.3 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding CLSD
# of Institutions
50Shares Held
11.6MCall Options Held
24KPut Options Held
12.1K-
Vanguard Group Inc Valley Forge, PA2.81MShares$2.53 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$1.98 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.93MShares$1.74 Million0.03% of portfolio
-
Black Rock Inc. New York, NY798KShares$718,3230.0% of portfolio
-
Geode Capital Management, LLC Boston, MA764KShares$687,6520.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $54.2M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...